Hightide Therapeutics Inc (HK:2511)

:2511

2511

Hightide Therapeutics Inc

RESEARCH TOOLSreports

Compare Hightide Therapeutics Inc (2511) vs. Competitors

1 Followers

Comparison Results

2511

Hightide Therapeutics Inc

HK$3.05

HK$1.82B

-2.75

145.07%

―

CANbridge Pharmaceuticals Inc.

HK$2.52

HK$1.62B

72.25

1442.86%

―

Mabpharm Limited

HK$0.50

HK$1.92B

33.28

-2.04%

―

SinoMab Bioscience Ltd.

HK$1.39

HK$2.24B

-14.44

46.02%

―

Transcenta Holding Limited

HK$2.25

HK$1.24B

-3.97

136.44%

―

Cutia Therapeutics

HK$4.59

HK$1.68B

-4.07

4.05%

1 Buy

0 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

2511 vs 2487

xxxxxxxxxxxxx

Performance Comparison

HK:2511

Hightide Therapeutics Inc

3.48

1.98

132.00%

HK:1228

CANbridge Pharmaceuticals Inc.

2.70

2.54

1587.50%

HK:2181

Mabpharm Limited

0.48

0.00

0.00%

HK:3681

SinoMab Bioscience Ltd.

1.65

0.50

43.48%

HK:6628

Transcenta Holding Limited

2.79

1.56

126.83%

HK:2487

Cutia Therapeutics

4.62

0.07

1.54%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >